Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.60p
   
  • Change Today:
    -0.78p
  • 52 Week High: 17.60p
  • 52 Week Low: 1.09p
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 3,961,499
  • Market Cap: £58.32m
  • RiskGrade: 328

Regulatory News

Launch of Website; Corporate Update 23-Oct-2025 07:00 RNS
Appointment of Independent Non-Executive Director 13-Oct-2025 07:00 RNS
Holding(s) in Company 06-Oct-2025 15:22 RNS
Exercise of Warrants 17-Sep-2025 07:00 RNS
Exercise of Warrants 11-Sep-2025 07:00 RNS
Appointments of CSO and Head of R&D 01-Sep-2025 14:12 RNS
ImmuPharma Files New Patent Application for P140: 01-Sep-2025 13:20 RNS
Holding(s) in Company 20-Aug-2025 13:36 RNS
Interim Results 06-Aug-2025 07:00 RNS
Result of AGM 12-Jun-2025 12:51 RNS
Holding(s) in Company 27-May-2025 15:13 RNS
Notice of AGM 20-May-2025 07:00 RNS
Final Results 19-May-2025 07:00 RNS
Warrant Extension, Debt Conversion & Equity Issue 01-Apr-2025 07:00 RNS
Extension of Warrants in Incanthera to 30 Sep 2025 01-Apr-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 11.60p
Change Today -0.78p
% Change -6.26 %
52 Week High 17.60p
52 Week Low 1.09p
Volume 3,961,499
Shares Issued 502.72m
Market Cap £58.32m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
16:30 77 @ 10.70p
16:30 125 @ 10.70p
16:30 112 @ 10.70p
16:30 64 @ 11.80p
15:50 100,000 @ 10.95p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page